Adaptate Biotherapeutics
London
About Adaptate Biotherapeutics
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ. The company was founded in 2019 by Adrian Hayday and is headquartered in London.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.2M
- Funding stage: M&A
- Last round: Series A (Apr 2021)
- Website: adaptate.com
- Phone: 02081947650
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adaptate-biotherapeutics-195059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.